Apparently Nonspecific Enzyme Elevations After Portal Vein Delivery of Recombinant Adeno-Associated Virus Serotype 2 Vector in Hepatitis C Virus-Infected Chimpanzees

Terence R. Flotte(University of Massachusetts Chan Medical School), Barry J. Byrne(University of Florida), Joseph G. P. Paolillo(University of Florida), Mark Potter(University of Florida), James G. Caridi(University of Florida), Jason Goetzmann(University of Louisiana at Lafayette), Christian Mueller(AbbVie (Germany)), Thomas J. Conlon(Adelson Foundation)
Human Gene Therapy
June 27, 2008
10.1089/hum.2007.174
Cited by 9

Related Papers

Treatment of Leber Congenital Amaurosis Due to <i>RPE65</i> Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial
|Human Gene Therapy|2008|950
Recombinant Adeno-Associated Virus Serotype 9 Leads to Preferential Cardiac Transduction In Vivo
|Circulation Research|2006|400
Mutational Analysis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Construction of AAV2 Vectors with Altered Tropism
|Journal of Virology|2000|392
Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy
|Proceedings of the National Academy of Sciences|2009|322
Human <i>RPE65</i> Gene Therapy for Leber Congenital Amaurosis: Persistence of Early Visual Improvements and Safety at 1 Year
|Human Gene Therapy|2009|312